Latest filings (excl ownership)
6-K
Company expects to report top-line data and complete study results in Q3 2024
13 Jun 24
424B3
Prospectus supplement
10 Jun 24
424B3
Prospectus supplement
10 Jun 24
424B3
Prospectus supplement
10 Jun 24
424B3
Prospectus supplement
10 Jun 24
6-K
Aeterna Zentaris and Ceapro Complete Merger Transaction
10 Jun 24
EFFECT
Notice of effectiveness
5 Jun 24
EFFECT
Notice of effectiveness
5 Jun 24
EFFECT
Notice of effectiveness
5 Jun 24
S-8
Registration of securities for employees
30 May 24
POS AM
Prospectus update (post-effective amendment)
30 May 24
POS AM
Prospectus update (post-effective amendment)
30 May 24
POS AM
Prospectus update (post-effective amendment)
30 May 24
6-K/A
Current report (foreign) (amended)
29 May 24
6-K
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
17 May 24
FWP
Free writing prospectus
17 May 24
EFFECT
Notice of effectiveness
17 May 24
6-K
Current report (foreign)
15 May 24
FWP
Free writing prospectus
15 May 24
FWP
Free writing prospectus
15 May 24
6-K
Consolidated Financial Statements
14 May 24
6-K
Current report (foreign)
13 May 24
6-K
Material Change Report
8 May 24
6-K
Aeterna Zentaris Announces Effective Date of Share Consolidation
1 May 24
F-1/A
Registration statement (foreign) (amended)
29 Apr 24
6-K
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
28 Mar 24
20-F
2023 FY
Annual report (foreign)
27 Mar 24
6-K
Consolidated Financial Statements
27 Mar 24
6-K
Current report (foreign)
27 Mar 24
6-K
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12 Mar 24
6-K
Amendment to Arrangement Agreement
26 Feb 24
6-K
Current report (foreign)
26 Feb 24
6-K
Current report (foreign)
16 Feb 24
F-1
Registration statement (foreign)
15 Feb 24
20-F/A
2022 FY
Annual report (foreign) (amended)
15 Feb 24
6-K/A
Current report (foreign) (amended)
22 Dec 23
6-K
Current report (foreign)
21 Dec 23
6-K
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
14 Dec 23
6-K
Current report (foreign)
9 Nov 23
6-K
Aeterna Zentaris Reports Third Quarter 2023 Financial Results
9 Nov 23
Latest ownership filings
SC 13G
Goodwood Inc.
6 Jun 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
11 Feb 22
SC 13G/A
Lind Global Macro Fund LP
11 Feb 22
SC 13G/A
ARMISTICE CAPITAL, LLC
16 Feb 21
SC 13G/A
Lind Global Macro Fund LP
12 Feb 21
SC 13G/A
INTRACOASTAL CAPITAL, LLC
29 Jan 21
SC 13G
INTRACOASTAL CAPITAL, LLC
10 Jul 20
SC 13G
Lind Global Macro Fund LP
7 Jul 20
SC 13G
Aeterna Zentaris Inc.
28 Feb 20
SC 13G/A
Aeterna Zentaris Inc.
14 Feb 20
SC 13G/A
Aeterna Zentaris Inc.
23 Jan 20
SC 13G
Aeterna Zentaris Inc.
27 Sep 19
SC 13G
Aeterna Zentaris Inc.
25 Sep 19
SC 13G/A
Aeterna Zentaris Inc.
15 Mar 19
SC 13G
Aeterna Zentaris Inc.
11 Feb 19
SC 13G/A
Aeterna Zentaris Inc.
9 Jan 17
SC 13G/A
Aeterna Zentaris Inc.
12 Feb 16
SC 13G/A
Aeterna Zentaris Inc.
14 Jan 16
SC 13G
Aeterna Zentaris Inc.
17 Dec 15
SC 13G
Aeterna Zentaris Inc.
13 Mar 15
SC 13G/A
Aeterna Zentaris Inc.
13 Feb 14
SC 13G
Aeterna Zentaris Inc.
29 Nov 13
SC 13D
SOCIETE GENERALE DE FINANCEMENT DU QUEBEC
27 Jul 10
SC 13D
SOCIETE GENERALE DE FINANCEMENT DU QUEBEC
16 Jun 10
SC 13D
SOCIETE GENERALE DE FINANCEMENT DU QUEBEC
18 May 10
SC 13D
SOCIETE GENERALE DE FINANCEMENT DU QUEBEC
17 May 10
SC 13D
SOCIETE GENERALE DE FINANCEMENT DU QUEBEC
14 May 10